Qisda Gestion
Gestion contrôle des critères 2/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Peter Chen
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | 12.3yrs |
| Propriété du PDG | 0.1% |
| Durée moyenne d'occupation des postes de direction | 3.3yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 4.5yrs |
Mises à jour récentes de la gestion
Recent updates
Mise à jour de l'analyse • Apr 02
2352: Steady Fair Value And Refined Assumptions Will Support Future Upside
Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.Mise à jour de l'analyse • Mar 19
2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside
Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.Mise à jour de l'analyse • Mar 04
2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price
Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.Mise à jour de l'analyse • Feb 18
2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price
Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Nouvelle analyse • Feb 06
AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround
Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?Mise à jour de l'analyse • Feb 03
2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price
Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.Mise à jour de l'analyse • Jan 19
2352: Stable Long Term Assumptions Will Support A Higher Future Share Price
Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.Mise à jour de l'analyse • Jan 05
2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price
Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.Mise à jour de l'analyse • Dec 14
2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance
Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.Mise à jour de l'analyse • Nov 29
2352: Lower Profit Margins Will Give Way To Future Share Price Upside
Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.Mise à jour de l'analyse • Nov 15
2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside
Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.Mise à jour de l'analyse • Nov 01
2352: Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.Mise à jour de l'analyse • Oct 17
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.Mise à jour de l'analyse • Oct 03
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.Mise à jour de l'analyse • Sep 17
Investments In AIoT And Medical Services Will Boost Future Profitability
The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.Mise à jour de l'analyse • Sep 02
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
Nouvelle analyse • Feb 21
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.Article d'analyse • Mar 12
Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture
The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...Article d'analyse • Mar 09
Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Article d'analyse • Feb 29
Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Article d'analyse • Mar 15
Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?
Dividend paying stocks like Qisda Corporation ( TPE:2352 ) tend to be popular with investors, and for good reason...Article d'analyse • Feb 26
Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Qisda's (TPE:2352) stock is up by a considerable 32% over the past three months. However, we decided to pay attention...Article d'analyse • Feb 08
These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d'analyse • Jan 24
Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...Article d'analyse • Jan 09
Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...PDG
Peter Chen (64 yo)
12.3yrs
Titularisation
Mr. Chi-Hong Chen, also known as Peter, is Non Executive Chairperson of BenQ BM Holding Cayman Corporation from March 22, 2024 and serves as its Director since May 27, 2013. Mr. Chen joined the BenQ BM Hol...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Chairman | no data | pas de données | 0.13% NT$ 49.2m | |
| President | no data | pas de données | pas de données | |
| VP, CFO & Accounting Officer | no data | pas de données | 0.038% NT$ 14.8m | |
| VP and Chief HR | 4.3yrs | pas de données | 0.015% NT$ 5.8m | |
| President of the Network Communication Business Unit | 2.3yrs | pas de données | pas de données | |
| Vice Chairman & Director | no data | pas de données | 0.045% NT$ 17.6m | |
| VP & President of the Medical Devices Products Group | no data | pas de données | pas de données | |
| GM of Manufacturing Operations & MD of Qisda China | 2.3yrs | pas de données | pas de données | |
| CIO | no data | pas de données | pas de données | |
| Chief Information Security Officer | 6.2yrs | pas de données | pas de données | |
| VP & GM of Information Technology Business Group | no data | pas de données | pas de données | |
| VP & GM of Commercial & Industrial Business Group | no data | pas de données | 0.0031% NT$ 1.2m |
3.3yrs
Durée moyenne de l'emploi
Gestion expérimentée: L'équipe de direction de 2352 est considérée comme expérimentée (ancienneté moyenne 3.3 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Chairman | 12.3yrs | pas de données | 0.13% NT$ 49.2m | |
| Vice Chairman & Director | 8.9yrs | pas de données | 0.045% NT$ 17.6m | |
| Director | 3yrs | pas de données | 0.000030% NT$ 11.8k | |
| Independent Director | 5.9yrs | pas de données | pas de données | |
| Independent Director | 5.9yrs | pas de données | pas de données | |
| Independent Director | 3yrs | pas de données | pas de données | |
| Independent Director | 3yrs | pas de données | pas de données | |
| Independent Director | 3yrs | pas de données | pas de données |
4.5yrs
Durée moyenne de l'emploi
64yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de 2352 sont considérés comme expérimentés (ancienneté moyenne 4.5 ans).
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/09 08:43 |
| Cours de l'action en fin de journée | 2026/05/08 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Qisda Corporation est couverte par 6 analystes. 1 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Nicholas Teo | CLSA |
| Joey Cheng | Goldman Sachs |
| null null | KGI Securities Co. Ltd. |